Global Pharmaceutical Products and CMO Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

Table of Contents

1 Pharmaceutical Products and CMO Market Overview

• 1.1 Product Overview and Scope of Pharmaceutical Products and CMO
• 1.2 Classification of Pharmaceutical Products and CMO by Types
  • 1.2.1 Global Pharmaceutical Products and CMO Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Pharmaceutical Products and CMO Revenue Market Share by Types in 2018
  • 1.2.3 Active Pharmaceutical Ingredient (API)
  • 1.2.4 Finished Dosage Form (FDF)
  • 1.2.5 Pharmaceutical Packaging
• 1.3 Global Pharmaceutical Products and CMO Market by Application
  • 1.3.1 Global Pharmaceutical Products and CMO Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Specialty/Midsize
  • 1.3.3 Generics
  • 1.3.4 Big Pharma
  • 1.3.5 Others
• 1.4 Global Pharmaceutical Products and CMO Market by Regions
  • 1.4.1 Global Pharmaceutical Products and CMO Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Pharmaceutical Products and CMO Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Pharmaceutical Products and CMO Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pharmaceutical Products and CMO Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Pharmaceutical Products and CMO Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pharmaceutical Products and CMO Status and Prospect (2014-2024)
• 1.5 Global Market Size of Pharmaceutical Products and CMO (2014-2024)

2 Manufacturers Profiles

• 2.1 Catalent
  • 2.1.1 Business Overview
  • 2.1.2 Pharmaceutical Products and CMO Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Catalent Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 DPx
  • 2.2.1 Business Overview
  • 2.2.2 Pharmaceutical Products and CMO Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 DPx Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Lonza
  • 2.3.1 Business Overview
  • 2.3.2 Pharmaceutical Products and CMO Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Lonza Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Piramal Healthcare
  • 2.4.1 Business Overview
  • 2.4.2 Pharmaceutical Products and CMO Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Piramal Healthcare Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Aenova
  • 2.5.1 Business Overview
  • 2.5.2 Pharmaceutical Products and CMO Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Aenova Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Jubilant
  • 2.6.1 Business Overview
  • 2.6.2 Pharmaceutical Products and CMO Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Jubilant Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Famar
  • 2.7.1 Business Overview
  • 2.7.2 Pharmaceutical Products and CMO Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Famar Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Boehringer Ingelheim
  • 2.8.1 Business Overview
  • 2.8.2 Pharmaceutical Products and CMO Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Boehringer Ingelheim Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Fareva Holding
  • 2.9.1 Business Overview
  • 2.9.2 Pharmaceutical Products and CMO Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Fareva Holding Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 AbbVie
  • 2.10.1 Business Overview
  • 2.10.2 Pharmaceutical Products and CMO Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 AbbVie Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Nipro Corp
  • 2.11.1 Business Overview
  • 2.11.2 Pharmaceutical Products and CMO Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Nipro Corp Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Vetter
  • 2.12.1 Business Overview
  • 2.12.2 Pharmaceutical Products and CMO Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Vetter Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Sopharma
  • 2.13.1 Business Overview
  • 2.13.2 Pharmaceutical Products and CMO Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Sopharma Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Mylan (DPT Laboratories)
  • 2.14.1 Business Overview
  • 2.14.2 Pharmaceutical Products and CMO Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Recipharm
  • 2.15.1 Business Overview
  • 2.15.2 Pharmaceutical Products and CMO Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Recipharm Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 NextPharma Technologies
  • 2.16.1 Business Overview
  • 2.16.2 Pharmaceutical Products and CMO Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 NextPharma Technologies Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 Dishman
  • 2.17.1 Business Overview
  • 2.17.2 Pharmaceutical Products and CMO Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 Dishman Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)
• 2.18 Aesica
  • 2.18.1 Business Overview
  • 2.18.2 Pharmaceutical Products and CMO Type and Applications
    • 2.18.2.1 Product A
    • 2.18.2.2 Product B
  • 2.18.3 Aesica Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2017-2018)

3 Global Pharmaceutical Products and CMO Market Competition, by Players

• 3.1 Global Pharmaceutical Products and CMO Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Pharmaceutical Products and CMO Players Market Share
  • 3.2.2 Top 10 Pharmaceutical Products and CMO Players Market Share
• 3.3 Market Competition Trend

4 Global Pharmaceutical Products and CMO Market Size by Regions

• 4.1 Global Pharmaceutical Products and CMO Revenue and Market Share by Regions
• 4.2 North America Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 4.3 Europe Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 4.5 South America Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)

5 North America Pharmaceutical Products and CMO Revenue by Countries

• 5.1 North America Pharmaceutical Products and CMO Revenue by Countries (2014-2019)
• 5.2 USA Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 5.3 Canada Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)

6 Europe Pharmaceutical Products and CMO Revenue by Countries

• 6.1 Europe Pharmaceutical Products and CMO Revenue by Countries (2014-2019)
• 6.2 Germany Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 6.3 UK Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 6.4 France Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 6.5 Russia Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 6.6 Italy Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Pharmaceutical Products and CMO Revenue by Countries

• 7.1 Asia-Pacific Pharmaceutical Products and CMO Revenue by Countries (2014-2019)
• 7.2 China Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 7.3 Japan Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 7.4 Korea Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 7.5 India Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)

8 South America Pharmaceutical Products and CMO Revenue by Countries

• 8.1 South America Pharmaceutical Products and CMO Revenue by Countries (2014-2019)
• 8.2 Brazil Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Pharmaceutical Products and CMO by Countries

• 9.1 Middle East and Africa Pharmaceutical Products and CMO Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 9.3 UAE Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Pharmaceutical Products and CMO Revenue and Growth Rate (2014-2019)

10 Global Pharmaceutical Products and CMO Market Segment by Type

• 10.1 Global Pharmaceutical Products and CMO Revenue and Market Share by Type (2014-2019)
• 10.2 Global Pharmaceutical Products and CMO Market Forecast by Type (2019-2024)
• 10.3 Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2014-2024)
• 10.4 Finished Dosage Form (FDF) Revenue Growth Rate (2014-2024)
• 10.5 Pharmaceutical Packaging Revenue Growth Rate (2014-2024)

11 Global Pharmaceutical Products and CMO Market Segment by Application

• 11.1 Global Pharmaceutical Products and CMO Revenue Market Share by Application (2014-2019)
• 11.2 Pharmaceutical Products and CMO Market Forecast by Application (2019-2024)
• 11.3 Specialty/Midsize Revenue Growth (2014-2019)
• 11.4 Generics Revenue Growth (2014-2019)
• 11.5 Big Pharma Revenue Growth (2014-2019)
• 11.6 Others Revenue Growth (2014-2019)

12 Global Pharmaceutical Products and CMO Market Size Forecast (2019-2024)

• 12.1 Global Pharmaceutical Products and CMO Market Size Forecast (2019-2024)
• 12.2 Global Pharmaceutical Products and CMO Market Forecast by Regions (2019-2024)
• 12.3 North America Pharmaceutical Products and CMO Revenue Market Forecast (2019-2024)
• 12.4 Europe Pharmaceutical Products and CMO Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Pharmaceutical Products and CMO Revenue Market Forecast (2019-2024)
• 12.6 South America Pharmaceutical Products and CMO Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Pharmaceutical Products and CMO Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology